• About
    Our Story Honorary President Big Issue Team Consultants
  • Investment
    Stretagies Portfolio
  • Pharmacetical
  • Corporate Governance
    Board of Directors Audit Committee Remuneration Committee Internal Audit Major Internal Policies
  • ESG
    Overview Sustainable Governance Environment Mangement Diversity, Equity & Inclusion Social Relationships Downloads
  • Investors
    Financials
    Financial Reports Operating Revenue
    Events
    Market Observation Post System
  • News
  • Careers
    Job Openings
  • Contact

繁體中文

News

  • 2022-01-13

    迎向國際!晟德轉投資東曜藥業與科興製藥簽訂樸欣汀® 海外市場商業化合作協定

  • 2021-12-23

    【代轉發】林榮錦對最高法院2021.12.23判決結果的聲明

  • 2021-12-22

    晟德轉投資公司東曜藥業與濟民可信簽署樸欣汀®中國大陸獨家銷售合約

  • 2021-12-01

    重磅消息!晟德轉投資公司東曜藥業貝伐珠單抗注射液樸欣汀®獲批上市

  • 2021-11-11

    晟德公佈110年第三季合併財報

  • 2021-11-02

    晟德(4123)瞄準新一代創新療法關鍵技術 催生集團獨角獸養成

  • 2021-10-27

    晟德(4123)策略性轉讓澳優乳業部份持股 預估獲利近42億元

  • 2021-08-12

    晟德上半年EPS高達7.29元 創歷年同期新高

  • 2021-08-10

    2021.08.10 晟德聲明書

  • 2021-08-06

    晟德擬與品晟醫藥簽署糖尿病新藥CS02之中國獨家合作協議

1 上一頁 5 6 7 8 9 下一頁 18

HEAD OFFICE
TEL:+886 2 2655-8680
FAX:+886 2 2655-8380
7F., No.3-2, Park St., Nangang Dist.,
Taipei City 115, Taiwan (R.O.C.)

  • About Our Story Honorary President Big Issue Team Consultants
  • Investment Stretagies Portfolio
    Pharmacetical
  • Corporate Governance Board of Directors Audit Committee Remuneration Committee Internal Audit Major Internal Policies
  • ESG Overview Sustainable Governance Environment Mangement Diversity, Equity & Inclusion Social Relationships Downloads
  • Investors Financial Reports Operating Revenue Events Market Observation Post System
  • News
    Careers Job Openings
    Contact
Copyright © 2018 Center Ventures All right reserved. Web Design By rIDEA